Kasinath Viswanathan
Advinus Therapeutics LtdIndia
331159 RESULTS
Advinus Therapeutics LtdIndia
The University of Louisiana at Monroe Monroe , United States
pain & neurologyJapan
Chalmers University of Technology
COMMENT It is always encouraging when another model of ALS is published. The more models we have, the more we can find out and the faster we can get to therapies. This model specifically overexpresses a mutant form of FUS. The onset of disease occurs very early i
Pfizer
Chalmers University of Technology
Instiute of Psychiatry, King's College LondonLondon, United Kingdom
Giershausen, Germany
Uppsala University
PAPER Muratore CR, Rice HC, Srikanth P, Callahan DG, Shin T, Benjamin LN, Walsh DM, Selkoe DJ, Young-Pearse TL
PAPER Mandler M, Valera E, Rockenstein E, Weninger H, Patrick C, Adame A, Santic R, Meindl S, Vigl B, Smrzka O, Schneeberger A, Mattner F, Masliah E
PAPER Alves J, Alves-Costa F, Magalhães R, Gonçalves OF, Sampaio A
PAPER Kerbage C, Sadowsky CH, Tariot PN, Agronin M, Alva G, Turner FD, Nilan D, Cameron A, Cagle GD, Hartung PD
PAPER Pietrzak RH, Scott JC, Neumeister A, Lim YY, Ames D, Ellis KA, Harrington K, Lautenschlager NT, Szoeke C, Martins RN, Masters CL, Villemagne VL, Rowe CC, Maruff P, Australian Imaging, Biomarkers and Lifestyle (AIBL) Research Group
No filters selected